Susquehanna International Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108K Sell
10,330
-4,010
-28% -$39.1K ﹤0.01% 12287
2025
Q4
$165K Sell
14,340
-3,180
-18% -$49.1K ﹤0.01% 11073
2025
Q3
$426K Buy
17,520
+14,320
+448% +$239K ﹤0.01% 9332
2025
Q2
$52.8K Sell
3,200
-4,950
-61% -$85.5K ﹤0.01% 12092
2025
Q1
$148K Buy
8,150
+1,540
+23% +$44K ﹤0.01% 11242
2024
Q4
$245K Sell
6,610
-4,310
-39% -$165K ﹤0.01% 10259
2024
Q3
$349K Sell
10,920
-6,230
-36% -$346K ﹤0.01% 9272
2024
Q2
$1.41M Sell
17,150
-14,110
-45% -$1.53M ﹤0.01% 5809
2024
Q1
$4.53M Buy
31,260
+18,680
+148% +$1.58M ﹤0.01% 3780
2023
Q4
$1.16M Sell
12,580
-5,740
-31% -$584K ﹤0.01% 6621
2023
Q3
$3.02M Buy
18,320
+13,540
+283% +$1.76M ﹤0.01% 4373
2023
Q2
$302K Buy
4,780
+1,850
+63% +$112K ﹤0.01% 9419
2023
Q1
$99.6K Buy
2,930
+230
+9% +$12K ﹤0.01% 11304
2022
Q4
$156K Sell
2,700
-1,760
-39% -$109K ﹤0.01% 10450
2022
Q3
$419K Buy
+4,460
New +$635K ﹤0.01% 8944
2022
Q2
Sell
-2,510
Closed -$1.38M 12965
2022
Q1
$1.38M Buy
2,510
+2,040
+434% +$1.23M ﹤0.01% 6351
2021
Q4
$311K Sell
470
-5,080
-92% -$3.88M ﹤0.01% 10406
2021
Q3
$4.66M Buy
5,550
+3,340
+151% +$3.39M ﹤0.01% 4080
2021
Q2
$2.81M Buy
2,210
+1,650
+295% +$1.86M ﹤0.01% 5173
2021
Q1
$614K Sell
560
-1,020
-65% -$1.35M ﹤0.01% 8999
2020
Q4
$2.26M Sell
1,580
-120
-7% -$128K ﹤0.01% 4837
2020
Q3
$1.2M Sell
1,700
-230
-12% -$167K ﹤0.01% 5676
2020
Q2
$1.35M Sell
1,930
-690
-26% -$398K ﹤0.01% 5240
2020
Q1
$916K Buy
2,620
+1,380
+111% +$977K ﹤0.01% 5609
2019
Q4
$779K Buy
+1,240
New +$606K ﹤0.01% 6019

Other funds holding CDLX

Susquehanna International Group's CDLX Position: Q1 2026 in Review

Susquehanna International Group reduced its Cardlytics (CDLX) stake by 88% in Q1 2026, selling an estimated $119K and leaving 1,592 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12886.

Susquehanna International Group first reported a position in CDLX in Q3 2019 and has held it in 24 quarters since. The position peaked at $4.22M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Susquehanna International Group held 1,592 shares of Cardlytics worth $16.7K as of Q1 2026.
  • Susquehanna International Group sold 12,195 Cardlytics shares in Q1 2026, an estimated $119K.
  • Cardlytics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12886 holding.
  • Susquehanna International Group first reported a position in Cardlytics in Q3 2019 and has held it in 24 quarters since.
  • Susquehanna International Group's Cardlytics position peaked at $4.22M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.